Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
Jeevandeep Mishra, Assistant Professor at Indore Institute of Pharmacy, Pithampur Road, Opp. IIM, Rau, Indore, shared a post on LinkedIn about a recent article he co-authored with Nimita Manocha, adding:
”I am proud to share a significant milestone in my academic journey-my book chapter titled ‘Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview’ has been published with Bentham Science.
This work provides a detailed overview of thrombotic complications associated with COVID-19, highlighting the underlying pathophysiological mechanisms, including hyperinflammatory responses, platelet activation, and the coagulation cascade.
It also explores the increased risk of conditions such as venous thromboembolism (VTE), pulmonary embolism (PE), deep vein thrombosis (DVT), and arterial thrombosis in affected patients.
Being part of this research has been an enriching experience, allowing me to deepen my understanding of the clinical and molecular aspects of COVID-19 and its complications.
This publication reinforces my commitment to advancing knowledge in pharmacology and healthcare research. I look forward to contributing further to impactful scientific work that addresses real-world health challenges.
I would like to extend my heartfelt gratitude to Dr. Nimita Grover Manocha ma’am (Principal, IIP) for her constant support, guidance, and encouragement throughout this journey. ”
Title: Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview
Authors: Nimita Manocha, Jeevandeep Mishra

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 22, 2026, 17:50Karen Dorsett: A Quick Quiz That Could Change How You Think About Blood Clots
-
Jul 22, 2026, 17:34Liz Devlin: Supporting Safe Pregnancy in Women with HHT
-
Jul 22, 2026, 16:46Congressman Don Davis: Working Toward a Better Future for Rare Disease Patients
-
Jul 22, 2026, 16:04Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
-
Jul 22, 2026, 15:27Obstetric APS: From Standardized Anticoagulation to Biology-Driven Precision Care
-
Jul 22, 2026, 14:31What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT
-
Jul 22, 2026, 10:16Ney Carter Borges: Understanding Pathophysiology as the Foundation of Precision Cardiovascular Care
-
Jul 22, 2026, 10:01George Cieutat: Strengthening Connections Across the Bleeding Disorders Community